EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Akt2 regulates autophagy and osteogenesis in diabetic osteoporosis via PI3K/AKT/mTOR signaling axis

Qiaonan Ye, Ting Fu, Peixuan Li, Xuemei Long, Zhiyuan Zhang, Luwen Ye, Yanqiu Zhou, Shuanglin Peng, Qianke Tao, Jingang Xiao

Bone · 2026-03 · 204 · 117770

DOI: 10.1016/j.bone.2025.117770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026-03. Verfasst von Qiaonan Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Burn Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China; Luzhou Key Laboratory of Oral &…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Osteogenesis, Osteoporosis, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan University State Key Laboratory of Oral Diseases, Sichuan Province Health Commission, Southwest Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose-derived stem cells (ASCs) are crucial seed cells for bone defect repair. In diabetic osteoporosis (DOP), however, their osteogenic potential is impaired. This study found that ASCs from a pre-clinical DOP model, established in C57BL/6 J mice using a high-fat/high-sucrose diet combined with streptozotocin-induced insulin deficiency, exhibited suppressed osteogenic differentiation and impaired autophagy flux. This was accompanied by hyperactivation of the PI3K/AKT/mTOR signaling, particularly elevated AKT2 phosphorylation. Transcriptomic analysis confirmed enrichment of related pathways. Mechanistically, Akt2 overexpression suppressed osteogenesis and autophagy, while its knockdown restored both. Crucially, implanting shAkt2-treated DOP-ASCs into calvarial defects of DOP mice enhanced bone regeneration, improving bone volume, trabecular number, and collagen deposition. These findings identify Akt2 as a key regulator of ASC dysfunction in DOP and demonstrate that its targeted inhibition rescues osteogenic potential, offering a promising therapeutic strategy for diabetic osteoporotic bone repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktOsteogenesisOsteoporosisTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesAutophagyDiabetes ComplicationsAnimalsSignal TransductionMice, Inbred C57BLMiceDiabetes Mellitus, ExperimentalMaleCell Differentiation

Stichwörter der Autor:innen

Akt2AutophagyDiabetic osteoporosisOsteogenesisOsteogenic differentiationPI3K/AKT/mTOR

Substanzen

Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesAkt2 protein, mouse

Autor:innen und Institutionen

  • Department of Plastic and Burn Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China; Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomato…
  • Department of Stomatology, The People's Hospital of Dujiangyan, Dujiangyan Medical Center, Dujiangyan, 611830, China.
  • Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646000, China.
  • Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646000, China; Department of Oral Implantology, The Affiliated…
  • Department of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646000, China.

Förderung

  • Sichuan University State Key Laboratory of Oral Diseases
  • Sichuan Province Health Commission
  • Southwest Medical University
  • National Natural Science Foundation of China
  • National College Students Innovation and Entrepreneurship Training Program
  • Science and Technology Department of Sichuan Province

Zitieren

APA

Ye, Q., Fu, T., Li, P., Long, X., Zhang, Z., Ye, L., Zhou, Y., Peng, S., Tao, Q., & Xiao, J. (2026). Akt2 regulates autophagy and osteogenesis in diabetic osteoporosis via PI3K/AKT/mTOR signaling axis. Bone, 204, 117770. https://doi.org/10.1016/j.bone.2025.117770

Vancouver

Ye Q, Fu T, Li P, Long X, Zhang Z, Ye L, et al. Akt2 regulates autophagy and osteogenesis in diabetic osteoporosis via PI3K/AKT/mTOR signaling axis. Bone. 2026;204:117770. doi:10.1016/j.bone.2025.117770

BibTeX
@article{Ye2026,
  author = {Ye, Qiaonan and Fu, Ting and Li, Peixuan and Long, Xuemei and Zhang, Zhiyuan and Ye, Luwen and Zhou, Yanqiu and Peng, Shuanglin and Tao, Qianke and Xiao, Jingang},
  title = {Akt2 regulates autophagy and osteogenesis in diabetic osteoporosis via PI3K/AKT/mTOR signaling axis},
  journal = {Bone},
  year = {2026},
  volume = {204},
  pages = {117770},
  doi = {10.1016/j.bone.2025.117770}
}
Kostenlos starten →